Hasil Pencarian  ::  Simpan CSV :: Kembali

"Buku yang berjudul "Pharmacotherapy handbook" ini ditulis oleh Barbara G. Wells, Joseph T. Dipiro, Terry L. Schwinghammer, dan Cindi W. Hammilton. Buku ini membahas tentang penyakit dan gangguan kesehatan, seperti gangguan dermatologis, gangguan gastrointestinal, dan gangguan endokrinologis."

"Pharmacotherapy Handbook provides the critical information you need to make drug therapy decisions for more than 140 diseases and disorders commonly encountered in a clinical setting. Featuring a convenient alphabetized presentation, this handy guide utilizes text, tables, figures, and treatment algorithms to make important drug data readily accessible and easily understood."

"The most comprehensive, widely used, and evidence-based pharmacotherapy text available Hailed by Doody's Review Service as "one of the best in pharmacy" Pharmacotherapy: A Pathophysiologic Approach is unmatched in its ability to help students develop a mastery of evidence-based medicine for optimum patient outcomes. The eighth edition will feature the addition of SI units throughout and an increased number of global examples and clinical questions. Features Unparalleled guidance in the development of pharmaceutical care plans Full-color presentation Key Concepts in each chapter Critical Presentation boxes summarize common disease signs and symptoms Clinical Controversies boxes examin complicated issues you face when providing drug therapy NEW material added to the online learning center EXPANDED evidence-based recommendations EXPANDED coverage of timely issues such as palliative care and pain medicine Therapeutic recommendations in each disease-specific chapte"

"Pharmacotherapy: A Pathophysiologic Approach is written to help advance the quality of patient care through evidence-based medication therapy derived from sound pharmacotherapeutic principles. The scope of this trusted classic goes beyond drug indications and dosages to include the initial selection, proper administration, and monitoring of drugs. You will find everything you need to provide safe, effective drug therapy across the full range of therapeutic categories. This edition is enriched by more than 300 expert contributors, and every chapter has been revised and updated to reflect the latest evidence-based information and recommendations. Important features such as Key Concepts at the beginning of each chapter, Clinical Presentation tables that summarize disease signs and symptoms, and Clinical Controversies boxes that examine the complicated issues faced by students and clinicians in providing drug therapy make this text an essential learning tool for students, patient-focused pharmacists, and other health care providers."

"Summary: "The most comprehensive, widely used, and evidence-based pharmacotherapy text available Hailed by Doody's Review Service as "one of the best in pharmacy" Pharmacotherapy: A Pathophysiologic Approach is unmatched in its ability to help students develop a mastery of evidence-based medicine for optimum patient outcomes. The eighth edition will feature the addition of SI units throughout and an increased number of global examples and clinical questions. Features Unparalleled guidance in the development of pharmaceutical care plans Full-color presentation Key Concepts in each chapter Critical Presentation boxes summarize common disease signs and symptoms Clinical Controversies boxes examin complicated issues you face when providing drug therapy NEW material added to the online learning center EXPANDED evidence-based recommendations EXPANDED coverage of timely issues such as palliative care and pain medicine Therapeutic recommendations in each disease-specific chapter""

"The sensation of pain is the means by which the body is made urgently aware of the presence of tissue damage. Pain represents a protective reflex for self-preservation. It is often pain that brings the patient to the dental office but also can be the factor that keeps the patient from seeking treatment at the appropriate time.Pain control is of great importance in dental practice. The clinician has to know the functional neuroanatomy, peripheral and central nervous system pathways, pain modulating system and various categories of pain of the head, neck and face. Psychological and psychosocial factors also contribute to pain, whether pain arises endogenously from pathologic processes or exogenously from trauma or even dental treatment. The dentists task is threefold: first, to establish the correct diagnosis, second to find the cause of the pain, and third to select the treatment plan that the addresses the patients complaint. By knowing the classification of orofacial pain, the clinician will easily make a diagnosis and determine the cause of the pain. After establishing the physical diagnosis it is easy then to determine the therapy to be made. The treatment in managing dental pain from pharmacotherapy is still effective using analgesic and local anesthetic drug."

" ABSTRAKTuberkulosis TB ekstra paru merupakan penyakit infeksi yang banyak terjadi di Indonesia. Penelitian TB ekstra paru di Indonesia masih sedikit, tatalaksana TB ekstra paru, termasuk obat yang digunakan serta hasil pengobatannya juga masih jarang diteliti. Penelitian ini bertujuan mengetahui angka kejadian, karakteristik dan mengevaluasi pengobatan TB ekstra paru di Rumah Sakit dr. Esnawan Antariksa Halim Perdana Kusuma periode 1 Januari 2014 - 31 Desember 2017. Penelitian potong lintang ini menggunakan data sekunder dari data register DOTS TB dan data rekam medis di Rumah Sakit dr. Esnawan Antariksa Halim Perdana Kusuma periode 1 Januari 2014-31 Desember 2017. Dari 456 pasien TB, didapat 153 pasien TB ekstra paru 33,5 , dari jumlah tersebut ada 136 pasien TB ekstra paru dengan data yang lengkap dan di evaluasi. Sebagian besar pasien berusia muda 91,9 , usia rata-rata 36.6 tahun, jenis kelamin terbanyak adalah perempuan 62.5 . Jenis TB ekstra paru terbanyak adalah limfadenitis TB 55,9 . Sebanyak 85,3 pasien pengobatannya lengkap, 11 putus obat, 1,5 gagal, dan 2,2 pindah pelayanan pengobatan. Tidak didapatkan hubungan bermakna antara keberhasilan terapi dengan usia p = 0,58; PR 0,9, 95 CI : 0,763-1,14 , komorbiditas p = 0.25; PR = 0.9, 95 CI : 0.802 ndash; 1.049 , IMT < 18,5 p = 0,613; PR =0,6, 95 CI : 0,15-3,05 . Penambahan etambutol fase lanjutan kategori I, dan pemberian ofloksasin pada terapi kategori II, meskipun tidak sesuai dengan panduan terapi meningkatkan keberhasilan terapi p = 0.039; PR = 1.1, 95 CI : 1.037 ndash; 1.318 . Keberhasilan terapi dengan lama pengobatan ge; 9 bulan lebih baik dibandingkan dengan < 9 bulan, p = 0,001; PR=1,8 95 CI : 1,403-2,533 .Kesimpulan : Penambahan etambutol pada fase lanjutan kategori I meningkatkan keberhasilan terapi TB ekstra paru. Sebagian besar TB ekstra paru membutuhkan lama pengobatan lebih dari 9 bulan.

---

---

ABSTRACTTuberculosis TB extra pulmonary is a common infectious disease in Indonesia. Extra pulmonary TB research in Indonesia is still small, the management of extra pulmonary TB, including the medicine used and the result of treatment are also rarely studied. This study aims to determine the prevalence, characteristics and evaluate the treatment of extra pulmonary TB in dr. Esnawan Antariksa Halim Perdana Kusuma Hospital period January 1, 2014 - December 31, 2017. This cross-sectional study used secondary data from DOTS TB register data and medical record data in dr. Esnawan Antariksa Halim Perdana Kusuma Hospital period from 1 January 2014-31 through December 2017. Of the 456 TB patients, which of 153 extra pulmonary TB patients 33,5 were found, out of which there were 136 extra pulmonary TB patients with complete data and evaluation. Most of the patients were young 91,9 , the average age was 36,6 years, the majority of patient were female 62,5 . The most common types of TB were TB lymphadenitis 55,9 . Some 85,3 of patients was complete treatment, 11 loss to follow-up, 1,5 failed, and 2,2 transfer out. Significantly, there was no correlation between the success of therapy with age p= 0.58, PR = 0.9;95 CI: 0.763-1.14 , comorbidity p = 0.25; PR = 0.9, 95 CI : 0.802-1.049 , IMT "

"Corona Virus Disease 2019 (COVID-19) adalah penyakit menular yang disebabkan oleh virus severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) (Shereen, Khan, Kazmi, Bashi, & Siddique, 2020) Pusat Kesehatan Masyarakat adalah fasilitas pelayanan kesehatan yang menyelenggarakan upaya Kesehatan masyarakat dan upaya Kesehatan perseorangan tingkat pertama, dengan lebih mengutamakan upaya promotive dan preventif, untuk mencapai derajat Kesehatan masyarakat yang setinggi-tingginya di wilayah kerjanya (Kementerian Kesehatan Republik Indonesia, 2014). Tatalaksana pengobatan pasien COVID-19 di Indonesia mengacu pada Pedoman Tatalaksana COVID-19 edisi 4 yang diterbitkan pada bulan Januari 2022. Puskesmas Ps. Rebo memiliki 320 pasien COVID-19 pada bulan Januari hingga Maret 2022. Penelitian ini dilakukan untuk mendeskripsikan penggunaan antimikroba, mengidentifikasi masalah yang terjadi dalam alur penanganan pasien COVID-19, dan mengevaluasi penatalaksanaan pasien COVID-19 di Puskesmas Ps. Rebo. Berdasarkan penelitian, dapat disimpulkan bahwa 1. Antimikroba yang digunakan pada pasien COVID-19 di Puskesmas Ps. Rebo adalah favipiravir (80,3%); azitromisin (9,8%); oseltamivir (0,8%); ciprofloxacin (0,8%); amoxicillin (0,8%).

---

Corona Virus Disease 2019 (COVID-19) is an infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus (Shereen, Khan, Kazmi, Bashi, & Siddique, 2020) Community Health Centers are health care facilities which organizes community health efforts and individual health efforts at the first level, by prioritizing promotive and preventive efforts, to achieve the highest degree of public health in their working area (Ministry of Health of the Republic of Indonesia, 2014). The management of the treatment of COVID-19 patients in Indonesia refers to the 4th edition of the Guidelines for the Management of COVID-19 which was published in January 2022. The Ps. Rebo had 320 COVID-19 patients from January to March 2022. This research was conducted to describe the use of antimicrobials, identify problems that occur in the flow of handling COVID-19 patients, and evaluate the management of COVID-19 patients at the Ps Health Center. Rebo. Based on the research, it can be concluded that 1. Antimicrobials used on COVID-19 patients at the Ps. Rebo is favipiravir (80.3%); azithromycin (9.8%); oseltamivir (0.8%); ciprofloxacin (0.8%); amoxicillin (0.8%)."